ATE325095T1 - Piperidinderivate als kalium-kanal blockers - Google Patents

Piperidinderivate als kalium-kanal blockers

Info

Publication number
ATE325095T1
ATE325095T1 AT02793633T AT02793633T ATE325095T1 AT E325095 T1 ATE325095 T1 AT E325095T1 AT 02793633 T AT02793633 T AT 02793633T AT 02793633 T AT02793633 T AT 02793633T AT E325095 T1 ATE325095 T1 AT E325095T1
Authority
AT
Austria
Prior art keywords
channel blockers
potassium channel
piperidine derivatives
formula
therapy
Prior art date
Application number
AT02793633T
Other languages
English (en)
Inventor
Tomas Eriksson
Ghazi Noori
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE325095T1 publication Critical patent/ATE325095T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pulmonology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02793633T 2001-12-14 2002-12-11 Piperidinderivate als kalium-kanal blockers ATE325095T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0104251A SE0104251D0 (sv) 2001-12-14 2001-12-14 Novel compounds

Publications (1)

Publication Number Publication Date
ATE325095T1 true ATE325095T1 (de) 2006-06-15

Family

ID=20286353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02793633T ATE325095T1 (de) 2001-12-14 2002-12-11 Piperidinderivate als kalium-kanal blockers

Country Status (13)

Country Link
EP (1) EP1499590B8 (de)
AT (1) ATE325095T1 (de)
AU (1) AU2002359122A1 (de)
CA (1) CA2487365C (de)
CY (1) CY1106132T1 (de)
DE (1) DE60211223T2 (de)
DK (1) DK1499590T3 (de)
ES (1) ES2261773T3 (de)
MY (1) MY128924A (de)
PT (1) PT1499590E (de)
SE (1) SE0104251D0 (de)
TW (1) TWI255185B (de)
WO (1) WO2003051839A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
US7851615B2 (en) 2003-04-17 2010-12-14 Alnylam Pharmaceuticals, Inc. Lipophilic conjugated iRNA agents
US7723509B2 (en) 2003-04-17 2010-05-25 Alnylam Pharmaceuticals IRNA agents with biocleavable tethers
ES2702942T3 (es) 2003-04-17 2019-03-06 Alnylam Pharmaceuticals Inc Agentes de ARNi modificados
US8796436B2 (en) 2003-04-17 2014-08-05 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
US8017762B2 (en) 2003-04-17 2011-09-13 Alnylam Pharmaceuticals, Inc. Modified iRNA agents
CN101233107A (zh) * 2005-08-01 2008-07-30 阿斯利康(瑞典)有限公司 作为趋化因子受体调节剂用于治疗呼吸系统疾病的新哌啶衍生物
TW200734305A (en) * 2005-08-02 2007-09-16 Astrazeneca Ab New salt III
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
TW200738635A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
CA2620281A1 (en) * 2005-08-26 2007-03-01 Astrazeneca Ab A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma
TW200744612A (en) * 2005-08-26 2007-12-16 Astrazeneca Ab New combination
EP1801200B1 (de) * 2005-12-21 2010-03-31 F. Hoffmann-La Roche Ag Stabile, hERG darstellende Zellkulturen
US20080064884A1 (en) * 2006-05-10 2008-03-13 Astrazeneca Ab Novel Process 1
GB0702456D0 (en) 2007-02-08 2007-03-21 Astrazeneca Ab New combination
EP2125728A4 (de) * 2007-02-23 2011-06-22 Astrazeneca Ab Neue kombination von verbindungen, die für die behandlung von atemwegserkrankungen, insbesondere chronisch-obstruktiver atemwegserkrankung (copd) und asthma, bestimmt ist
WO2008121065A1 (en) * 2007-03-30 2008-10-09 Astrazeneca Ab Novel pyrrolidine derivatives as antagonists of the chemokine receptor
CA2708190A1 (en) 2007-12-20 2009-07-02 Astrazeneca Ab Dispenser and method for entraining powder in an airflow 537
WO2010042035A1 (en) 2008-10-08 2010-04-15 Astrazeneca Ab Inhaler with indexing linked to movement of cover
TW201036957A (en) 2009-02-20 2010-10-16 Astrazeneca Ab Novel salt 628
EP2448623B1 (de) 2009-07-01 2017-12-20 AstraZeneca AB Spender und verfahren zur einspeisung von pulver in einen luftstrom
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
WO2011073662A1 (en) 2009-12-17 2011-06-23 Astrazeneca Ab Combination of a benzoxazinone and a further agent for treating respiratory diseases
CN102858640B (zh) 2010-02-10 2015-12-09 阿斯利康英国有限公司 提供用于吸入器的填充罐的方法
CN103118727B (zh) 2010-07-21 2015-11-25 阿斯利康(瑞典)有限公司 吸入器
BR112013001342A2 (pt) 2010-07-21 2016-05-17 Astrazeneca Ab dispositivo
GB201021992D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab Compound
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound
WO2012163848A1 (en) 2011-05-27 2012-12-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of crohn's disease
GB201115874D0 (en) 2011-09-14 2011-10-26 Astrazeneca Ab Inhaler
GB201115870D0 (en) 2011-09-14 2011-10-26 Astrazeneca Ab Inhaler

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO5300399A1 (es) * 2000-02-25 2003-07-31 Astrazeneca Ab Heterocicliocs que contienen nitrogeno, proceso para su preparacion y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
TWI255185B (en) 2006-05-21
DE60211223T2 (de) 2007-04-19
EP1499590B8 (de) 2006-08-02
DK1499590T3 (da) 2006-07-31
EP1499590A1 (de) 2005-01-26
HK1071134A1 (en) 2005-07-08
MY128924A (en) 2007-02-28
TW200409631A (en) 2004-06-16
AU2002359122A1 (en) 2003-06-30
ES2261773T3 (es) 2006-11-16
EP1499590B1 (de) 2006-05-03
PT1499590E (pt) 2006-08-31
SE0104251D0 (sv) 2001-12-14
WO2003051839A1 (en) 2003-06-26
CA2487365C (en) 2009-06-16
CY1106132T1 (el) 2011-06-08
CA2487365A1 (en) 2003-06-26
DE60211223D1 (de) 2006-06-08

Similar Documents

Publication Publication Date Title
ATE325095T1 (de) Piperidinderivate als kalium-kanal blockers
IS6658A (is) Ný efnasambönd
IS6520A (is) Ný efnasambönd
SE0104140D0 (sv) Novel Compounds
SE9904652D0 (sv) Novel Compounds
SE0301700D0 (sv) Novel compounds
SE0202483D0 (sv) Chemical compounds
AU2002239344A1 (en) Pyrazolopyridines
MXPA03008754A (es) Derivados de piridina fundidos para utilizarse como agonistas receptores vaniloide para tratar dolor.
ATE316083T1 (de) Adamantanderivate
DE60003949D1 (de) 5-aryl-1h-1,2,4 triazolverbindungen als cyclooxygenase -2 inhibitoren und dieseenthaltende pharmazeutische zusammensetzungen
ATE300541T1 (de) Pyrazolopyridinderivate
MXPA05012247A (es) Derivados de bencimidazol nuevos.
SE0302139D0 (sv) Novel compounds
AU2001266575A1 (en) Chemical compounds
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
TW200604197A (en) New compounds
ATE498600T1 (de) Inden derivate als pharmazeutika
SE0101038D0 (sv) Novel compounds
IL173810A0 (en) Imidazopyridine derivatives and pharmaceutical compositions containing the same
SE0003476D0 (sv) Compounds
SE0303280D0 (sv) Novel compounds
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
TR200401052T4 (tr) Yeni bileşikler
ATE373000T1 (de) Pyrazolopyridin-derivate als antiherpesmittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1499590

Country of ref document: EP

REN Ceased due to non-payment of the annual fee